Skip to main navigation
Adamis
  • Contact Us
Select Page
  • About
    • Overview
    • Management
    • Board of Directors
  • Customized Medications
  • Products
  • Pipeline
    • Specialty Pharmaceuticals
    • APC – 1000
    • APC – 4000
    • APC – 6000
    • APC – 8000
  • Investors

    Investor Relations

    • Investors
    • Overview
    • News Releases
    • Stock Information
    • SEC Filings
    • Events and Presentations
    • Email Alerts
  • Careers
    • Partnerships
  • Contact Us

Events & Presentations

Investor Relations

  • Investors
  • Overview
  • News Releases
  • Stock Information
  • SEC Filings
  • Events and Presentations
  • Email Alerts

Tools

  • Print Page

Adamis Pharmaceuticals Announces 2019 Financial Results and Business Update

March 30, 2020

Adamis

  • About
  • Management
  • Board of Directors
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) is a specialty biopharmaceutical company focused on developing and commercializing pharmaceutical products in the therapeutic areas of respiratory disease and allergy.

  • Customized Medications

  • Products

  • Pipeline

  • Specialty Pharmaceuticals
    • APC – 6000
    • APC – 8000
  • Metered Dose Inhalers
    • APC – 1000
  • Dry Powder Inhaler Platform
    • APC – 4000
  • Partnerships

Investor Relations

  • Investors
  • Overview
  • News Releases
  • Stock Information
  • SEC Filings
  • Events and Presentations
  • Email Alerts
  • Careers
  • Partnerships

  • Contact Us
858.997.2400
  • Privacy Statement
  • Terms of Use

2021 Copyright Adamis Pharmaceuticals Corporation